{"schema_version":"alpha-governance-record-v2","alpha_id":"alpha:company:c90f9af3-f96a-4349-93af-372649ad337c","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce","ontology_version":"alpha-governance-ontology-v1","as_of":"2026-10-16T22:31:50.667579+00:00","published_at":"2026-10-16T13:52:04.878381+00:00","section":"events","data":{"state":"PUBLISHED","derivation_version":"alpha-governance-event-derivation-v2","events":[{"event_id":"alpha:event:transition:13lhtt5710qvx","event_type":"CFO_CHANGED","effective_at":"2026-04-21","detected_at":"2026-10-16T13:52:04.878381+00:00","subject_ids":["alpha:person:latha-vairavan-arqt","alpha:company:c90f9af3-f96a-4349-93af-372649ad337c"],"caused_claim_ids":["alpha:claim:company:c90f9af3-f96a-4349-93af-372649ad337c:leadership_role:16"],"evidence_ids":["alpha:projection-evidence:document:b746a9d3ae805ac7c55e12a716f6dd125f914b836b380d9d8f7cac438b3c93af"],"summary":"Latha Vairavan executive of Arcutis Biotherapeutics, Inc., effective 2026-04-21.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:selcmxkw36df","event_type":"EXECUTIVE_APPOINTED","effective_at":"2026-04-21","detected_at":"2026-10-16T13:52:04.878381+00:00","subject_ids":["alpha:person:lisa-m-edwards","alpha:company:c90f9af3-f96a-4349-93af-372649ad337c"],"caused_claim_ids":["alpha:claim:company:c90f9af3-f96a-4349-93af-372649ad337c:leadership_role:17"],"evidence_ids":["alpha:projection-evidence:document:4b79a8c2375aae1f70ff2766831d782c4a2abf0e6f551428444e677344b93984"],"summary":"Lisa M. Edwards executive of Arcutis Biotherapeutics, Inc., effective 2026-04-21.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1x28fe11yzxuuf","event_type":"GC_CHANGED","effective_at":"2026-04-21","detected_at":"2026-10-16T13:52:04.878381+00:00","subject_ids":["alpha:person:masaru-matsuda-arqt","alpha:company:c90f9af3-f96a-4349-93af-372649ad337c"],"caused_claim_ids":["alpha:claim:company:c90f9af3-f96a-4349-93af-372649ad337c:leadership_role:18"],"evidence_ids":["alpha:projection-evidence:document:14981a8b2a318c8a2212b50216e303413e06e3095204f1a9027dbd2ea862a28b"],"summary":"Masaru Matsuda executive of Arcutis Biotherapeutics, Inc., effective 2026-04-21.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:ds5x0p18jv0k1","event_type":"EXECUTIVE_APPOINTED","effective_at":"2026-04-21","detected_at":"2026-10-16T13:52:04.878381+00:00","subject_ids":["alpha:person:patrick-e-burnett-arqt","alpha:company:c90f9af3-f96a-4349-93af-372649ad337c"],"caused_claim_ids":["alpha:claim:company:c90f9af3-f96a-4349-93af-372649ad337c:leadership_role:19"],"evidence_ids":["alpha:projection-evidence:document:6a6c1b97868739621203bbf5f27374b6d07b93f1389ec4efb646c0e4c7aaea2e"],"summary":"Patrick E. Burnett executive of Arcutis Biotherapeutics, Inc., effective 2026-04-21.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1nf2if8mfhn18","event_type":"CEO_CHANGED","effective_at":"2026-04-21","detected_at":"2026-10-16T13:52:04.878381+00:00","subject_ids":["alpha:person:todd-franklin-watanabe-arqt","alpha:company:c90f9af3-f96a-4349-93af-372649ad337c"],"caused_claim_ids":["alpha:claim:company:c90f9af3-f96a-4349-93af-372649ad337c:leadership_role:20"],"evidence_ids":["alpha:projection-evidence:document:7d92283fe8b34bb38b22e269499dfa4caf7e75db91b3fa71afd05ea11177c617"],"summary":"Todd Franklin Watanabe executive of Arcutis Biotherapeutics, Inc., effective 2026-04-21.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:j52ucdpck6uj","event_type":"DIRECTOR_APPOINTED","effective_at":"2025-01-01","detected_at":"2026-10-16T13:52:04.878381+00:00","subject_ids":["alpha:person:amit-d-munshi","alpha:company:c90f9af3-f96a-4349-93af-372649ad337c"],"caused_claim_ids":["alpha:claim:company:c90f9af3-f96a-4349-93af-372649ad337c:leadership_role:5"],"evidence_ids":["alpha:projection-evidence:document:8d513e1bac3f8c4871b3cb40f50cee8907ff80535c3f30eda3dbd424b4594bd3"],"summary":"Amit D. Munshi seat on Arcutis Biotherapeutics, Inc., effective 2025-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1wu2n3pc2e2zf","event_type":"COMMITTEE_CREATED","effective_at":"2025-01-01","detected_at":"2026-10-16T13:52:04.878381+00:00","subject_ids":["alpha:committee:arcutis-biotherapeutics-inc:compensation-chair","alpha:company:c90f9af3-f96a-4349-93af-372649ad337c"],"caused_claim_ids":["alpha:claim:company:c90f9af3-f96a-4349-93af-372649ad337c:leadership_role:5"],"evidence_ids":["alpha:projection-evidence:document:8d513e1bac3f8c4871b3cb40f50cee8907ff80535c3f30eda3dbd424b4594bd3"],"summary":"Compensation · Chair committee of Arcutis Biotherapeutics, Inc., effective 2025-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:65cxqzfnfdw5","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2025-01-01","detected_at":"2026-10-16T13:52:04.878381+00:00","subject_ids":["alpha:person:amit-d-munshi","alpha:committee:arcutis-biotherapeutics-inc:compensation-chair"],"caused_claim_ids":["alpha:claim:company:c90f9af3-f96a-4349-93af-372649ad337c:leadership_role:5"],"evidence_ids":["alpha:projection-evidence:document:8d513e1bac3f8c4871b3cb40f50cee8907ff80535c3f30eda3dbd424b4594bd3"],"summary":"Amit D. Munshi member of Compensation · Chair, effective 2025-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:upiiye1rrp9k0","event_type":"DIRECTOR_APPOINTED","effective_at":"2022-01-01","detected_at":"2026-10-16T13:52:04.878381+00:00","subject_ids":["alpha:person:neha-krishnamohan","alpha:company:c90f9af3-f96a-4349-93af-372649ad337c"],"caused_claim_ids":["alpha:claim:company:c90f9af3-f96a-4349-93af-372649ad337c:leadership_role:9"],"evidence_ids":["alpha:projection-evidence:document:8d513e1bac3f8c4871b3cb40f50cee8907ff80535c3f30eda3dbd424b4594bd3"],"summary":"Neha Krishnamohan seat on Arcutis Biotherapeutics, Inc., effective 2022-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1yh8r301q83a2i","event_type":"DIRECTOR_APPOINTED","effective_at":"2021-01-01","detected_at":"2026-10-16T13:52:04.878381+00:00","subject_ids":["alpha:person:keith-r-leonard-jr","alpha:company:c90f9af3-f96a-4349-93af-372649ad337c"],"caused_claim_ids":["alpha:claim:company:c90f9af3-f96a-4349-93af-372649ad337c:leadership_role:8"],"evidence_ids":["alpha:projection-evidence:document:8d513e1bac3f8c4871b3cb40f50cee8907ff80535c3f30eda3dbd424b4594bd3"],"summary":"Keith R. Leonard, Jr. seat on Arcutis Biotherapeutics, Inc., effective 2021-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1bqossqevf62e","event_type":"DIRECTOR_APPOINTED","effective_at":"2021-01-01","detected_at":"2026-10-16T13:52:04.878381+00:00","subject_ids":["alpha:person:sue-jean-lin","alpha:company:c90f9af3-f96a-4349-93af-372649ad337c"],"caused_claim_ids":["alpha:claim:company:c90f9af3-f96a-4349-93af-372649ad337c:leadership_role:11"],"evidence_ids":["alpha:projection-evidence:document:8d513e1bac3f8c4871b3cb40f50cee8907ff80535c3f30eda3dbd424b4594bd3"],"summary":"Sue-Jean Lin seat on Arcutis Biotherapeutics, Inc., effective 2021-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1nbnyts26vcsq","event_type":"COMMITTEE_CREATED","effective_at":"2021-01-01","detected_at":"2026-10-16T13:52:04.878381+00:00","subject_ids":["alpha:committee:arcutis-biotherapeutics-inc:audit-chair-nominating-and-governance","alpha:company:c90f9af3-f96a-4349-93af-372649ad337c"],"caused_claim_ids":["alpha:claim:company:c90f9af3-f96a-4349-93af-372649ad337c:leadership_role:11"],"evidence_ids":["alpha:projection-evidence:document:8d513e1bac3f8c4871b3cb40f50cee8907ff80535c3f30eda3dbd424b4594bd3"],"summary":"Audit · Chair; Nominating and Governance committee of Arcutis Biotherapeutics, Inc., effective 2021-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:15dv0tl1fwbjdn","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2021-01-01","detected_at":"2026-10-16T13:52:04.878381+00:00","subject_ids":["alpha:person:sue-jean-lin","alpha:committee:arcutis-biotherapeutics-inc:audit-chair-nominating-and-governance"],"caused_claim_ids":["alpha:claim:company:c90f9af3-f96a-4349-93af-372649ad337c:leadership_role:11"],"evidence_ids":["alpha:projection-evidence:document:8d513e1bac3f8c4871b3cb40f50cee8907ff80535c3f30eda3dbd424b4594bd3"],"summary":"Sue-Jean Lin member of Audit · Chair; Nominating and Governance, effective 2021-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1fcync51928m3d","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2021-01-01","detected_at":"2026-10-16T13:52:04.878381+00:00","subject_ids":["alpha:person:keith-r-leonard-jr","alpha:committee:arcutis-biotherapeutics-inc:compensation"],"caused_claim_ids":["alpha:claim:company:c90f9af3-f96a-4349-93af-372649ad337c:committee_record:25"],"evidence_ids":["alpha:projection-evidence:4c9393562dcf5d3323b616fc87442ec78fcc110867b81d48c03e7d144b7c97e6"],"summary":"Keith R. Leonard, Jr. member of Compensation, effective 2021-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:d04ogn1223yx9","event_type":"DIRECTOR_APPOINTED","effective_at":"2020-01-01","detected_at":"2026-10-16T13:52:04.878381+00:00","subject_ids":["alpha:person:halley-e-gilbert","alpha:company:c90f9af3-f96a-4349-93af-372649ad337c"],"caused_claim_ids":["alpha:claim:company:c90f9af3-f96a-4349-93af-372649ad337c:leadership_role:6"],"evidence_ids":["alpha:projection-evidence:document:8d513e1bac3f8c4871b3cb40f50cee8907ff80535c3f30eda3dbd424b4594bd3"],"summary":"Halley E. Gilbert seat on Arcutis Biotherapeutics, Inc., effective 2020-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:ju8sdi1m6koj8","event_type":"DIRECTOR_APPOINTED","effective_at":"2020-01-01","detected_at":"2026-10-16T13:52:04.878381+00:00","subject_ids":["alpha:person:howard-g-welgus-m-d","alpha:company:c90f9af3-f96a-4349-93af-372649ad337c"],"caused_claim_ids":["alpha:claim:company:c90f9af3-f96a-4349-93af-372649ad337c:leadership_role:7"],"evidence_ids":["alpha:projection-evidence:document:8d513e1bac3f8c4871b3cb40f50cee8907ff80535c3f30eda3dbd424b4594bd3"],"summary":"Howard G. Welgus, M.D. seat on Arcutis Biotherapeutics, Inc., effective 2020-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:u3xr3y1hcxwqg","event_type":"DIRECTOR_APPOINTED","effective_at":"2020-01-01","detected_at":"2026-10-16T13:52:04.878381+00:00","subject_ids":["alpha:person:terrie-curran","alpha:company:c90f9af3-f96a-4349-93af-372649ad337c"],"caused_claim_ids":["alpha:claim:company:c90f9af3-f96a-4349-93af-372649ad337c:leadership_role:12"],"evidence_ids":["alpha:projection-evidence:document:8d513e1bac3f8c4871b3cb40f50cee8907ff80535c3f30eda3dbd424b4594bd3"],"summary":"Terrie Curran seat on Arcutis Biotherapeutics, Inc., effective 2020-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1vn97frxfah6x","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2020-01-01","detected_at":"2026-10-16T13:52:04.878381+00:00","subject_ids":["alpha:person:halley-e-gilbert","alpha:committee:arcutis-biotherapeutics-inc:audit"],"caused_claim_ids":["alpha:claim:company:c90f9af3-f96a-4349-93af-372649ad337c:committee_record:21"],"evidence_ids":["alpha:projection-evidence:4c9393562dcf5d3323b616fc87442ec78fcc110867b81d48c03e7d144b7c97e6"],"summary":"Halley E. Gilbert member of Audit, effective 2020-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:pus0aedddy08","event_type":"COMMITTEE_CREATED","effective_at":"2020-01-01","detected_at":"2026-10-16T13:52:04.878381+00:00","subject_ids":["alpha:committee:arcutis-biotherapeutics-inc:nominating-and-governance-chair","alpha:company:c90f9af3-f96a-4349-93af-372649ad337c"],"caused_claim_ids":["alpha:claim:company:c90f9af3-f96a-4349-93af-372649ad337c:leadership_role:12"],"evidence_ids":["alpha:projection-evidence:document:8d513e1bac3f8c4871b3cb40f50cee8907ff80535c3f30eda3dbd424b4594bd3"],"summary":"Nominating and Governance · Chair committee of Arcutis Biotherapeutics, Inc., effective 2020-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:17gd6g5rrlrqt","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2020-01-01","detected_at":"2026-10-16T13:52:04.878381+00:00","subject_ids":["alpha:person:terrie-curran","alpha:committee:arcutis-biotherapeutics-inc:nominating-and-governance-chair"],"caused_claim_ids":["alpha:claim:company:c90f9af3-f96a-4349-93af-372649ad337c:leadership_role:12"],"evidence_ids":["alpha:projection-evidence:document:8d513e1bac3f8c4871b3cb40f50cee8907ff80535c3f30eda3dbd424b4594bd3"],"summary":"Terrie Curran member of Nominating and Governance · Chair, effective 2020-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:11ohtj314zqm45","event_type":"DIRECTOR_APPOINTED","effective_at":"2017-01-01","detected_at":"2026-10-16T13:52:04.878381+00:00","subject_ids":["alpha:person:todd-franklin-watanabe","alpha:company:c90f9af3-f96a-4349-93af-372649ad337c"],"caused_claim_ids":["alpha:claim:company:c90f9af3-f96a-4349-93af-372649ad337c:leadership_role:13"],"evidence_ids":["alpha:projection-evidence:document:8d513e1bac3f8c4871b3cb40f50cee8907ff80535c3f30eda3dbd424b4594bd3"],"summary":"Todd Franklin Watanabe seat on Arcutis Biotherapeutics, Inc., effective 2017-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1kxmyn710mqrj7","event_type":"DIRECTOR_APPOINTED","effective_at":"2016-01-01","detected_at":"2026-10-16T13:52:04.878381+00:00","subject_ids":["alpha:person:patrick-j-heron","alpha:company:c90f9af3-f96a-4349-93af-372649ad337c"],"caused_claim_ids":["alpha:claim:company:c90f9af3-f96a-4349-93af-372649ad337c:leadership_role:10"],"evidence_ids":["alpha:projection-evidence:document:8d513e1bac3f8c4871b3cb40f50cee8907ff80535c3f30eda3dbd424b4594bd3"],"summary":"Patrick J. Heron seat on Arcutis Biotherapeutics, Inc., effective 2016-01-01.","derivation":"temporal_relationship_change"}]},"claims":[{"id":"alpha:claim:company:c90f9af3-f96a-4349-93af-372649ad337c:leadership_role:5","subject_id":"alpha:company:c90f9af3-f96a-4349-93af-372649ad337c","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:amit-d-munshi","object_label":"Amit D. Munshi","object_source_name_forms":[],"value":"Amit D. Munshi: Director, Compensation · Chair","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:amit-d-munshi","name":"Amit D. Munshi"},"title":"Director","role_category":"director","committee":"Compensation · Chair","is_board_chair":false,"is_independent":true,"start_date":"2025-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2025-01-01","valid_to":null,"recorded_at":"2026-10-16T13:52:04.878381+00:00","sources":[{"id":"alpha:projection-evidence:document:8d513e1bac3f8c4871b3cb40f50cee8907ff80535c3f30eda3dbd424b4594bd3","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Arcutis Biotherapeutics, Inc. DEF 14A 2026-04-21","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1787306/000178730626000028/arqt-20260421.htm","source_date":"2026-04-21","retrieved_at":"2026-04-24T15:49:02.01+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-21","effective_from":"2025-01-01","effective_until":null,"observed_at":"2026-10-16T13:52:04.878381+00:00","reviewed_at":"2026-10-16T13:52:04.878381+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:c90f9af3-f96a-4349-93af-372649ad337c:leadership_role:6","subject_id":"alpha:company:c90f9af3-f96a-4349-93af-372649ad337c","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:halley-e-gilbert","object_label":"Halley E. Gilbert","object_source_name_forms":[],"value":"Halley E. Gilbert: Director, Audit","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:halley-e-gilbert","name":"Halley E. Gilbert"},"title":"Director","role_category":"director","committee":"Audit","is_board_chair":false,"is_independent":true,"start_date":"2020-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2020-01-01","valid_to":null,"recorded_at":"2026-10-16T13:52:04.878381+00:00","sources":[{"id":"alpha:projection-evidence:document:8d513e1bac3f8c4871b3cb40f50cee8907ff80535c3f30eda3dbd424b4594bd3","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Arcutis Biotherapeutics, Inc. DEF 14A 2026-04-21","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1787306/000178730626000028/arqt-20260421.htm","source_date":"2026-04-21","retrieved_at":"2026-04-24T15:49:02.01+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-21","effective_from":"2020-01-01","effective_until":null,"observed_at":"2026-10-16T13:52:04.878381+00:00","reviewed_at":"2026-10-16T13:52:04.878381+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:c90f9af3-f96a-4349-93af-372649ad337c:leadership_role:7","subject_id":"alpha:company:c90f9af3-f96a-4349-93af-372649ad337c","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:howard-g-welgus-m-d","object_label":"Howard G. Welgus, M.D.","object_source_name_forms":[],"value":"Howard G. Welgus, M.D.: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:howard-g-welgus-m-d","name":"Howard G. Welgus, M.D."},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2020-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2020-01-01","valid_to":null,"recorded_at":"2026-10-16T13:52:04.878381+00:00","sources":[{"id":"alpha:projection-evidence:document:8d513e1bac3f8c4871b3cb40f50cee8907ff80535c3f30eda3dbd424b4594bd3","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Arcutis Biotherapeutics, Inc. DEF 14A 2026-04-21","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1787306/000178730626000028/arqt-20260421.htm","source_date":"2026-04-21","retrieved_at":"2026-04-24T15:49:02.01+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-21","effective_from":"2020-01-01","effective_until":null,"observed_at":"2026-10-16T13:52:04.878381+00:00","reviewed_at":"2026-10-16T13:52:04.878381+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:c90f9af3-f96a-4349-93af-372649ad337c:leadership_role:8","subject_id":"alpha:company:c90f9af3-f96a-4349-93af-372649ad337c","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:keith-r-leonard-jr","object_label":"Keith R. Leonard, Jr.","object_source_name_forms":[],"value":"Keith R. Leonard, Jr.: Director, Compensation","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:keith-r-leonard-jr","name":"Keith R. Leonard, Jr."},"title":"Director","role_category":"director","committee":"Compensation","is_board_chair":false,"is_independent":true,"start_date":"2021-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2021-01-01","valid_to":null,"recorded_at":"2026-10-16T13:52:04.878381+00:00","sources":[{"id":"alpha:projection-evidence:document:8d513e1bac3f8c4871b3cb40f50cee8907ff80535c3f30eda3dbd424b4594bd3","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Arcutis Biotherapeutics, Inc. DEF 14A 2026-04-21","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1787306/000178730626000028/arqt-20260421.htm","source_date":"2026-04-21","retrieved_at":"2026-04-24T15:49:02.01+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-21","effective_from":"2021-01-01","effective_until":null,"observed_at":"2026-10-16T13:52:04.878381+00:00","reviewed_at":"2026-10-16T13:52:04.878381+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:c90f9af3-f96a-4349-93af-372649ad337c:leadership_role:9","subject_id":"alpha:company:c90f9af3-f96a-4349-93af-372649ad337c","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:neha-krishnamohan","object_label":"Neha Krishnamohan","object_source_name_forms":[],"value":"Neha Krishnamohan: Director, Audit","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:neha-krishnamohan","name":"Neha Krishnamohan"},"title":"Director","role_category":"director","committee":"Audit","is_board_chair":false,"is_independent":true,"start_date":"2022-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2022-01-01","valid_to":null,"recorded_at":"2026-10-16T13:52:04.878381+00:00","sources":[{"id":"alpha:projection-evidence:document:8d513e1bac3f8c4871b3cb40f50cee8907ff80535c3f30eda3dbd424b4594bd3","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Arcutis Biotherapeutics, Inc. DEF 14A 2026-04-21","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1787306/000178730626000028/arqt-20260421.htm","source_date":"2026-04-21","retrieved_at":"2026-04-24T15:49:02.01+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-21","effective_from":"2022-01-01","effective_until":null,"observed_at":"2026-10-16T13:52:04.878381+00:00","reviewed_at":"2026-10-16T13:52:04.878381+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:c90f9af3-f96a-4349-93af-372649ad337c:leadership_role:10","subject_id":"alpha:company:c90f9af3-f96a-4349-93af-372649ad337c","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:patrick-j-heron","object_label":"Patrick J. Heron","object_source_name_forms":[],"value":"Patrick J. Heron: Director, Compensation","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:patrick-j-heron","name":"Patrick J. Heron"},"title":"Director","role_category":"director","committee":"Compensation","is_board_chair":false,"is_independent":true,"start_date":"2016-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2016-01-01","valid_to":null,"recorded_at":"2026-10-16T13:52:04.878381+00:00","sources":[{"id":"alpha:projection-evidence:document:8d513e1bac3f8c4871b3cb40f50cee8907ff80535c3f30eda3dbd424b4594bd3","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Arcutis Biotherapeutics, Inc. DEF 14A 2026-04-21","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1787306/000178730626000028/arqt-20260421.htm","source_date":"2026-04-21","retrieved_at":"2026-04-24T15:49:02.01+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-21","effective_from":"2016-01-01","effective_until":null,"observed_at":"2026-10-16T13:52:04.878381+00:00","reviewed_at":"2026-10-16T13:52:04.878381+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:c90f9af3-f96a-4349-93af-372649ad337c:leadership_role:11","subject_id":"alpha:company:c90f9af3-f96a-4349-93af-372649ad337c","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:sue-jean-lin","object_label":"Sue-Jean Lin","object_source_name_forms":[],"value":"Sue-Jean Lin: Director, Audit · Chair; Nominating and Governance","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:sue-jean-lin","name":"Sue-Jean Lin"},"title":"Director","role_category":"director","committee":"Audit · Chair; Nominating and Governance","is_board_chair":false,"is_independent":true,"start_date":"2021-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2021-01-01","valid_to":null,"recorded_at":"2026-10-16T13:52:04.878381+00:00","sources":[{"id":"alpha:projection-evidence:document:8d513e1bac3f8c4871b3cb40f50cee8907ff80535c3f30eda3dbd424b4594bd3","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Arcutis Biotherapeutics, Inc. DEF 14A 2026-04-21","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1787306/000178730626000028/arqt-20260421.htm","source_date":"2026-04-21","retrieved_at":"2026-04-24T15:49:02.01+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-21","effective_from":"2021-01-01","effective_until":null,"observed_at":"2026-10-16T13:52:04.878381+00:00","reviewed_at":"2026-10-16T13:52:04.878381+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:c90f9af3-f96a-4349-93af-372649ad337c:leadership_role:12","subject_id":"alpha:company:c90f9af3-f96a-4349-93af-372649ad337c","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:terrie-curran","object_label":"Terrie Curran","object_source_name_forms":[],"value":"Terrie Curran: Director, Nominating and Governance · Chair","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:terrie-curran","name":"Terrie Curran"},"title":"Director","role_category":"director","committee":"Nominating and Governance · Chair","is_board_chair":false,"is_independent":true,"start_date":"2020-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2020-01-01","valid_to":null,"recorded_at":"2026-10-16T13:52:04.878381+00:00","sources":[{"id":"alpha:projection-evidence:document:8d513e1bac3f8c4871b3cb40f50cee8907ff80535c3f30eda3dbd424b4594bd3","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Arcutis Biotherapeutics, Inc. DEF 14A 2026-04-21","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1787306/000178730626000028/arqt-20260421.htm","source_date":"2026-04-21","retrieved_at":"2026-04-24T15:49:02.01+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-21","effective_from":"2020-01-01","effective_until":null,"observed_at":"2026-10-16T13:52:04.878381+00:00","reviewed_at":"2026-10-16T13:52:04.878381+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:c90f9af3-f96a-4349-93af-372649ad337c:leadership_role:13","subject_id":"alpha:company:c90f9af3-f96a-4349-93af-372649ad337c","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:todd-franklin-watanabe","object_label":"Todd Franklin Watanabe","object_source_name_forms":[],"value":"Todd Franklin Watanabe: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:todd-franklin-watanabe","name":"Todd Franklin Watanabe"},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":false,"start_date":"2017-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2017-01-01","valid_to":null,"recorded_at":"2026-10-16T13:52:04.878381+00:00","sources":[{"id":"alpha:projection-evidence:document:8d513e1bac3f8c4871b3cb40f50cee8907ff80535c3f30eda3dbd424b4594bd3","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Arcutis Biotherapeutics, Inc. DEF 14A 2026-04-21","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1787306/000178730626000028/arqt-20260421.htm","source_date":"2026-04-21","retrieved_at":"2026-04-24T15:49:02.01+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-21","effective_from":"2017-01-01","effective_until":null,"observed_at":"2026-10-16T13:52:04.878381+00:00","reviewed_at":"2026-10-16T13:52:04.878381+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:c90f9af3-f96a-4349-93af-372649ad337c:leadership_role:16","subject_id":"alpha:company:c90f9af3-f96a-4349-93af-372649ad337c","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:latha-vairavan-arqt","object_label":"Latha Vairavan","object_source_name_forms":[],"value":"Latha Vairavan: Senior Vice President and Chief Financial Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:latha-vairavan-arqt","name":"Latha Vairavan"},"title":"Senior Vice President and Chief Financial Officer","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-04-21","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-04-21","valid_to":null,"recorded_at":"2026-10-16T13:52:04.878381+00:00","sources":[{"id":"alpha:projection-evidence:document:b746a9d3ae805ac7c55e12a716f6dd125f914b836b380d9d8f7cac438b3c93af","identity_scope":"source_document_reference","source_type":"sec_filing","title":"ARQT DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1787306/000178730626000028/arqt-20260421.htm","source_date":"2026-04-21T00:00:00+00:00","retrieved_at":"2026-05-14T23:38:00.639995+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-21T00:00:00+00:00","effective_from":"2026-04-21","effective_until":null,"observed_at":"2026-10-16T13:52:04.878381+00:00","reviewed_at":"2026-10-16T13:52:04.878381+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:c90f9af3-f96a-4349-93af-372649ad337c:leadership_role:17","subject_id":"alpha:company:c90f9af3-f96a-4349-93af-372649ad337c","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:lisa-m-edwards","object_label":"Lisa M. Edwards","object_source_name_forms":[],"value":"Lisa M. Edwards: Executive Vice President and Chief Commercial Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:lisa-m-edwards","name":"Lisa M. Edwards"},"title":"Executive Vice President and Chief Commercial Officer","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-04-21","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-04-21","valid_to":null,"recorded_at":"2026-10-16T13:52:04.878381+00:00","sources":[{"id":"alpha:projection-evidence:document:4b79a8c2375aae1f70ff2766831d782c4a2abf0e6f551428444e677344b93984","identity_scope":"source_document_reference","source_type":"sec_filing","title":"ARQT DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1787306/000178730626000028/arqt-20260421.htm","source_date":"2026-04-21T00:00:00+00:00","retrieved_at":"2026-05-14T23:38:00.0729+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-21T00:00:00+00:00","effective_from":"2026-04-21","effective_until":null,"observed_at":"2026-10-16T13:52:04.878381+00:00","reviewed_at":"2026-10-16T13:52:04.878381+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:c90f9af3-f96a-4349-93af-372649ad337c:leadership_role:18","subject_id":"alpha:company:c90f9af3-f96a-4349-93af-372649ad337c","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:masaru-matsuda-arqt","object_label":"Masaru Matsuda","object_source_name_forms":[],"value":"Masaru Matsuda: Executive Vice President, Chief Legal Officer and Corporate Secretary","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:masaru-matsuda-arqt","name":"Masaru Matsuda"},"title":"Executive Vice President, Chief Legal Officer and Corporate Secretary","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-04-21","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-04-21","valid_to":null,"recorded_at":"2026-10-16T13:52:04.878381+00:00","sources":[{"id":"alpha:projection-evidence:document:14981a8b2a318c8a2212b50216e303413e06e3095204f1a9027dbd2ea862a28b","identity_scope":"source_document_reference","source_type":"sec_filing","title":"ARQT DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1787306/000178730626000028/arqt-20260421.htm","source_date":"2026-04-21T00:00:00+00:00","retrieved_at":"2026-05-14T23:37:59.636231+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-21T00:00:00+00:00","effective_from":"2026-04-21","effective_until":null,"observed_at":"2026-10-16T13:52:04.878381+00:00","reviewed_at":"2026-10-16T13:52:04.878381+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:c90f9af3-f96a-4349-93af-372649ad337c:leadership_role:19","subject_id":"alpha:company:c90f9af3-f96a-4349-93af-372649ad337c","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:patrick-e-burnett-arqt","object_label":"Patrick E. Burnett","object_source_name_forms":[],"value":"Patrick E. Burnett: Executive Vice President and Chief Medical Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:patrick-e-burnett-arqt","name":"Patrick E. Burnett"},"title":"Executive Vice President and Chief Medical Officer","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-04-21","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-04-21","valid_to":null,"recorded_at":"2026-10-16T13:52:04.878381+00:00","sources":[{"id":"alpha:projection-evidence:document:6a6c1b97868739621203bbf5f27374b6d07b93f1389ec4efb646c0e4c7aaea2e","identity_scope":"source_document_reference","source_type":"sec_filing","title":"ARQT DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1787306/000178730626000028/arqt-20260421.htm","source_date":"2026-04-21T00:00:00+00:00","retrieved_at":"2026-05-14T23:37:59.141206+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-21T00:00:00+00:00","effective_from":"2026-04-21","effective_until":null,"observed_at":"2026-10-16T13:52:04.878381+00:00","reviewed_at":"2026-10-16T13:52:04.878381+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:c90f9af3-f96a-4349-93af-372649ad337c:leadership_role:20","subject_id":"alpha:company:c90f9af3-f96a-4349-93af-372649ad337c","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:todd-franklin-watanabe-arqt","object_label":"Todd Franklin Watanabe","object_source_name_forms":[],"value":"Todd Franklin Watanabe: President, Chief Executive Officer and Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:todd-franklin-watanabe-arqt","name":"Todd Franklin Watanabe"},"title":"President, Chief Executive Officer and Director","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-04-21","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-04-21","valid_to":null,"recorded_at":"2026-10-16T13:52:04.878381+00:00","sources":[{"id":"alpha:projection-evidence:document:7d92283fe8b34bb38b22e269499dfa4caf7e75db91b3fa71afd05ea11177c617","identity_scope":"source_document_reference","source_type":"sec_filing","title":"ARQT DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1787306/000178730626000028/arqt-20260421.htm","source_date":"2026-04-21T00:00:00+00:00","retrieved_at":"2026-05-14T23:37:58.728451+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-21T00:00:00+00:00","effective_from":"2026-04-21","effective_until":null,"observed_at":"2026-10-16T13:52:04.878381+00:00","reviewed_at":"2026-10-16T13:52:04.878381+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:c90f9af3-f96a-4349-93af-372649ad337c:committee_record:21","subject_id":"alpha:company:c90f9af3-f96a-4349-93af-372649ad337c","predicate":"alpha:hasBoardCommittee","object_id":null,"object_label":null,"object_source_name_forms":[],"value":"Audit: Chair Sue-Jean Lin; Members Sue-Jean Lin (Chair); Halley E. Gilbert; Neha Krishnamohan","claim_type":"committee_record","predicate_id":"alpha:predicate:committee_record","predicate_version":1,"machine_key":"committee_record","human_label":"Committee Record","governed_predicate":true,"machine_value":{"name":"Audit","canonical_type":"audit","chair":"Sue-Jean Lin","members":[{"display_name":"Sue-Jean Lin","person_slug":"sue-jean-lin","is_chair":true},{"display_name":"Halley E. Gilbert","person_slug":"halley-e-gilbert","is_chair":false},{"display_name":"Neha Krishnamohan","person_slug":"neha-krishnamohan","is_chair":false}],"source_id":"board_seats"},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-16T13:52:04.878381+00:00","sources":[{"id":"alpha:projection-evidence:4c9393562dcf5d3323b616fc87442ec78fcc110867b81d48c03e7d144b7c97e6","identity_scope":"representation_reference","source_type":"board_seats","title":"Audit","publisher":"board_seats","url":"https://www.sec.gov/Archives/edgar/data/1787306/000178730626000028/arqt-20260421.htm","source_date":null,"retrieved_at":null,"locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-16T13:52:04.878381+00:00","reviewed_at":"2026-10-16T13:52:04.878381+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:c90f9af3-f96a-4349-93af-372649ad337c:committee_record:25","subject_id":"alpha:company:c90f9af3-f96a-4349-93af-372649ad337c","predicate":"alpha:hasBoardCommittee","object_id":null,"object_label":null,"object_source_name_forms":[],"value":"Compensation: Chair Amit D. Munshi; Members Amit D. Munshi (Chair); Keith R. Leonard, Jr.; Patrick J. Heron","claim_type":"committee_record","predicate_id":"alpha:predicate:committee_record","predicate_version":1,"machine_key":"committee_record","human_label":"Committee Record","governed_predicate":true,"machine_value":{"name":"Compensation","canonical_type":"compensation","chair":"Amit D. Munshi","members":[{"display_name":"Amit D. Munshi","person_slug":"amit-d-munshi","is_chair":true},{"display_name":"Keith R. Leonard, Jr.","person_slug":"keith-r-leonard-jr","is_chair":false},{"display_name":"Patrick J. Heron","person_slug":"patrick-j-heron","is_chair":false}],"source_id":"board_seats"},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-16T13:52:04.878381+00:00","sources":[{"id":"alpha:projection-evidence:4c9393562dcf5d3323b616fc87442ec78fcc110867b81d48c03e7d144b7c97e6","identity_scope":"representation_reference","source_type":"board_seats","title":"Audit","publisher":"board_seats","url":"https://www.sec.gov/Archives/edgar/data/1787306/000178730626000028/arqt-20260421.htm","source_date":null,"retrieved_at":null,"locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-16T13:52:04.878381+00:00","reviewed_at":"2026-10-16T13:52:04.878381+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"}],"evidence":[{"id":"alpha:projection-evidence:document:8d513e1bac3f8c4871b3cb40f50cee8907ff80535c3f30eda3dbd424b4594bd3","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Arcutis Biotherapeutics, Inc. DEF 14A 2026-04-21","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1787306/000178730626000028/arqt-20260421.htm","source_date":"2026-04-21","retrieved_at":"2026-04-24T15:49:02.01+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:b746a9d3ae805ac7c55e12a716f6dd125f914b836b380d9d8f7cac438b3c93af","identity_scope":"source_document_reference","source_type":"sec_filing","title":"ARQT DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1787306/000178730626000028/arqt-20260421.htm","source_date":"2026-04-21T00:00:00+00:00","retrieved_at":"2026-05-14T23:38:00.639995+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:4b79a8c2375aae1f70ff2766831d782c4a2abf0e6f551428444e677344b93984","identity_scope":"source_document_reference","source_type":"sec_filing","title":"ARQT DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1787306/000178730626000028/arqt-20260421.htm","source_date":"2026-04-21T00:00:00+00:00","retrieved_at":"2026-05-14T23:38:00.0729+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:14981a8b2a318c8a2212b50216e303413e06e3095204f1a9027dbd2ea862a28b","identity_scope":"source_document_reference","source_type":"sec_filing","title":"ARQT DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1787306/000178730626000028/arqt-20260421.htm","source_date":"2026-04-21T00:00:00+00:00","retrieved_at":"2026-05-14T23:37:59.636231+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:6a6c1b97868739621203bbf5f27374b6d07b93f1389ec4efb646c0e4c7aaea2e","identity_scope":"source_document_reference","source_type":"sec_filing","title":"ARQT DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1787306/000178730626000028/arqt-20260421.htm","source_date":"2026-04-21T00:00:00+00:00","retrieved_at":"2026-05-14T23:37:59.141206+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:7d92283fe8b34bb38b22e269499dfa4caf7e75db91b3fa71afd05ea11177c617","identity_scope":"source_document_reference","source_type":"sec_filing","title":"ARQT DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1787306/000178730626000028/arqt-20260421.htm","source_date":"2026-04-21T00:00:00+00:00","retrieved_at":"2026-05-14T23:37:58.728451+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:4c9393562dcf5d3323b616fc87442ec78fcc110867b81d48c03e7d144b7c97e6","identity_scope":"representation_reference","source_type":"board_seats","title":"Audit","publisher":"board_seats","url":"https://www.sec.gov/Archives/edgar/data/1787306/000178730626000028/arqt-20260421.htm","source_date":null,"retrieved_at":null,"locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"coverage_state":"PUBLISHED","quality":{"schema_version":"alpha-record-quality-v2","overall":0.834,"status":"strong","publication_readiness":"ready","dimensions":{"identity":1,"coverage":0.5,"freshness":1,"evidence_completeness":1,"source_authority":0.865,"cross_source_agreement":0.75,"temporal_completeness":0.583},"diagnostics":{"published_claims":31,"factual_claims":31,"claims_with_linked_evidence":31,"disputed_claims":0,"conflicts":0,"stale_claims":0,"stale_claim_ids":[],"temporal_claims":24,"temporal_claims_with_valid_from":14,"missing_coverage_sections":["governance","financials","workforce","ownership","ratings"],"missing_expected_claims":["headquarters","official_website","financial_metric","governance_document","ownership","auditor","legal_matter","risk","ai_governance"]},"derivation":"deterministic_record_projection"},"publication":{"state":"PUBLISHED","published_at":"2026-10-16T13:52:04.878381+00:00","observed_at":"2026-10-16T13:52:04.878381+00:00","reviewed_at":"2026-10-16T13:52:04.878381+00:00","verified_at":"2026-10-16T13:52:04.878381+00:00"},"verification":{"schema_version":"alpha-verification-states-v1","state":"source_reported","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":31,"corroborated":0,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"Published claims are reported by public sources; none is Alpha verified. Profile ownership is unclaimed.","facets":[{"facet":"identity","state":"unclaimed"},{"facet":"evidence","state":"source_reported"},{"facet":"evaluation","state":"not_evaluated"},{"facet":"monitoring","state":null},{"facet":"authority","state":null},{"facet":"freshness","state":"current"}]},"rights":{"public_retrieval":"allowed","agent_retrieval":"allowed","redistribution":"not_granted","model_training":"not_granted","commercial_use":"not_specified","relationship_pathfinding":"not_granted","direct_contact":"not_granted"},"resource":{"uri":"alpha://company/arcutis-biotherapeutics-inc/events","section":"events","href":"https://registry.alpha.ac/api/public/companies/arcutis-biotherapeutics-inc?format=record&section=events","media_type":"application/json","availability":"contract"},"limitations":["Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.","Only explicitly published canonical company identity and current confirmed public roles are included.","Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.","Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.","This Company Profile is an identity and evidence record, not an Alpha rating."]}